Potential Health Benefits of Green Tea (Camellia sinensis): A Narrative Review

Explore: The Journal of Science and Healing

Volumn 2, Issue 6, 2006, Pages 531-539

  Pastore, Robert L ^a   Fratellone, Patrick ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARYL SULFOTRANSFERASE; CAFFEIC ACID; CHLOROGENIC ACID; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; GALLIC ACID; GELATINASE A; GELATINASE B; GREEN TEA EXTRACT; INTERLEUKIN 1BETA; KAEMPFEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MYRICETIN; ORNITHINE DECARBOXYLASE; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT MEDICINAL PRODUCT; POLYPHENOL; POTASSIUM CHANNEL HERG; QUERCETIN; SIALIDASE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; UROKINASE; WARFARIN;

ALOPECIA; ANTIVIRAL ACTIVITY; APOPTOSIS; AREA UNDER THE CURVE; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BLADDER CANCER; BREAST CANCER; CANCER INHIBITION; CANDIDA ALBICANS; COLORECTAL CANCER; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG HALF LIFE; DRUG INDICATION; DRUG RESPONSE; DRUG STRUCTURE; DRUG URINE LEVEL; ENTERITIS; ESOPHAGUS CANCER; HEART ARRHYTHMIA; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA VIRUS; LEUKEMIA; LIVER DISEASE; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; NEUROPROTECTION; NONHUMAN; OSTEOSARCOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RHEUMATIC DISEASE; SJOEGREN SYNDROME; SKIN CANCER; STOMACH CANCER; STRUCTURE ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; UTERINE CERVIX CANCER; WEIGHT REDUCTION;

ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; CAMELLIA SINENSIS; CATECHIN; DIABETES MELLITUS; FEMALE; FREE RADICAL SCAVENGERS; HIV INFECTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKEMIA; LIVER DISEASES; MALE; NEOPLASMS; PLANT EXTRACTS; TEA;

EID: 33750958473     PISSN: 15508307     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.explore.2006.08.008     Document Type: Article

References (68)

1. Graham H.N. Green tea composition, consumption, and polyphenol chemistry. Prev Med 21 (1992) 334-350
2. Min Z., and Peigen X. Quantitative analysis of the active constituents in green tea. Phytother Res 5 (1991) 239-240
3. US Department of Agriculture. USDA Database for the Flavonoid Contents of Selected Foods (2003), US Department of Agriculture, Beltsville, MD March
4. Lee M.J., Maliakal P., Chen L., et al. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 11 10 Pt 1 (2002) 1025-1032
5. Chow H.H., Cai Y., Hakim I.A., et al. Safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 9 (2003) 3312-3319
6. Song J.M., Lee K.H., and Seong B.L. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res 68 (2005) 66-74
7. Sueoka N., Suganuma M., Sueoka E., et al. A new function of green tea: prevention of lifestyle-related diseases. Ann N Y Acad Sci 928 (2001) 274-280
8. Vinson J.A. Black and green tea and heart disease: a review. Biofactors 13 (2000) 127-132
9. Hirano-Ohmori R., Takahashi R., Momiyama Y., et al. Green tea consumption and serum malondialdehyde-modified LDL concentrations in healthy subjects. J Am Coll Nutr 24 (2005) 342-346
10. Lill G., Voit S., Schror K., and Weber A.A. Complex effects of different green tea catechins on human platelets. FEBS Lett 546 (2003) 265-270
11. Tokunaga S., White I.R., Frost C., et al. Green tea consumption and serum lipids and lipoproteins in a population of healthy workers in Japan. Ann Epidemiol 12 (2002) 157-165
12. Bursill C.A., and Roach P.D. Modulation of cholesterol metabolism by the green tea polyphenol (-)-epigallocatechin gallate in cultured human liver (HepG2) cells. J Agric Food Chem 54 (2006) 1621-1626
13. Hertog M.G., Kromhout D., Aravanis C., et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 155 (1995) 381-386
14. Hollman P.C.H., Feskens E.J.M., and Katan M.B. Tea flavonols in cardiovascular disease and cancer epidemiology. Proc Soc Exp Biol Med 220 (1999) 198-202
15. Hsu S., and Dickinson D. A new approach to managing oral manifestations of Sjogren's syndrome and skin manifestations of lupus. J Biochem Mol Biol 39 (2006) 229-239
16. Varilek G.W., Yang F., Lee E.Y., et al. Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J Nutr 131 (2001) 2034-2039
17. Kelemen K, Kiesecker C, Zitron E, et al. Green tea flavonoid inhibits "human-ether-a-gogo related gene" (HERG) potassium channels. Paper presented at: Heart Rhythm Society's 25th Annual Scientific Sessions; May 19-22, 2004; San Francisco, Calif.
18. Fujiki H., Suganuma M., Kurusu M., et al. New TNF-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen. Mutat Res (2003) 523-524 119-125
19. Fujiki H., Suganuma M., Okabe S., et al. A. New concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (-)-epigallocatechin gallate and green tea-a review. Cancer Detect Prev 24 (2000) 91-99
20. Fujiki H., Suganuma M., Okabe S., et al. Mechanistic findings of green tea as cancer preventive for humans. Proc Soc Exp Biol Med 220 (1999) 225-228
21. Bertolini F., Fusetti L., Rabascio C., Cinieri S., Martinelli G., and Pruneri G. Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade non-Hodgkin's lymphoma. Leukemia 14 (2000) 1477-1482
22. Bushman J.L. Green tea and cancer in humans: a review of the literature. Nutr Cancer 31 (1998) 151-159
23. Chen J.J., Ye Z.Q., and Koo M.W. Growth inhibition and cell cycle arrest effects of epigallocatechin gallate in the NBT-II bladder tumour cell line. BJU Int 93 (2004) 1082-1086
24. Qing-Yi L., Yu-Sheng J., Allan P., et al. Green tea extract modulates actin remodeling via rho activity in an in vitro multistep carcinogenic model. Clin Cancer Res 11 (2005) 1675-1683
25. Rosengren R.J. Catechins and the treatment of breast cancer: possible utility and mechanistic targets. IDrugs 6 (2003) 1073-1078
26. Fujiki H. Two stages of cancer prevention with green tea. J Cancer Res Clin Oncol 125 (1999) 589-597
27. Ahn W.S., Huh S.W., Bae S.M., et al. A major constituent of green tea. EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression. DNA Cell Biol 22 (2003) 217-224
28. Orner G.A., Dashwood M., Blum C., Díaz G., Li Q., and Dashwood R. Suppression of tumorigenesis in the Apcmin mouse: down-regulation of β-catenin signaling by a combination of tea plus sulindac. Carcinogenesis 24 (2003) 263-267
29. Tamura H., and Matsui M. Inhibitory effects of green tea and grape juice on the phenol sulfotransferase activity of mouse intestines and human colon carcinoma cell line Caco-2. Biol Pharm Bull 23 (2000) 695-699
30. Hasan M., and Nihal A. Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 71; (2000) 1698S-1702S
31. Gao Y.T., McLaughlin J.K., Blot W.J., et al. Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst 86 (1994) 855-858
32. Hasan M., and Nihal A. Tea polyphenols: prevention of cancer and optimizing health. Epidemiology 12 (2001) 695-700
33. Fujimoto N., Sueoka N., Sueoka E., et al. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1. Int J Oncol 20 (2002) 1233-1239
34. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1. Oncol Rep 13 (2005) 253-257
35. Takada M., Nakamura Y., Koizumi T., et al. Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas 25 (2003) 45-48
36. Paschka A.G., Butler R., and Young C.Y. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett 130 (1998) 1-7
37. Liao S., and Hipakka R.A. Selective inhibition of steroid 5a -reductase [5AR] by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem Biophys Res Commun 214 (1995) 833-838
38. Jankun J., Selman S.H., Swiercz R., and Skrzypczak-Jankun E. Why drinking green tea could prevent cancer. Nature 387 (1997) 561
39. Liao S., Umekita Y., Guo J., Kokontis J.M., and Hiipakka R.A. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett 96 (1995) 239-243
40. Santosh K., and Hasan M. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress. J Leukoc Biol 69 (2001) 719-726
41. Hibasami H., Komiya T., Achiwa Y., et al. Induction of apoptosis in human stomach cancer cells by green tea catechins. Oncol Rep 5 (1998) 527-529
42. Lee Y., Bone N., Strege A., Shanafelt T., Jelinek D., and Kay N. VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood 104 (2004) 788-794
43. Nance C.L., and Shearer W.T. Is green tea good for HIV-1 infection?. J Allergy Clin Immunol 112 (2003) 851-853
44. Esfandiari A., and Kelley P. The effects of tea polyphenolic compounds on hair loss among rodents. J Natl Med Assoc 97 (2005) 816-818
45. Hsu S., Bollag W., Lewis J., et al. Green tea polyphenols induce differentiation and proliferation in epidermal keratinocytes. J Pharmacol Exp Ther 306 (2003) 29-34
46. Murase T., Haramizu S., Shimotoyodome A., Nagasawa A., and Tokimitsu I. Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice. Am J Physiol Regul Integr Comp Physiol 57 (2004) 708-715
47. Ahmed S., Rahman A., Hasnain A., Lalonde M., Goldberg V.M., and Haqqi T.M. Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Biol Med 15 (2002) 33 :1097-1105
48. Adcocks C., Collin P., and Buttle D. Catechins from green tea (Camellia sinensis) inhibit bovine and human cartilage proteoglycan and type II collagen degradation in vitro. J Nutr 132 (2002) 341-346
49. Dryden G., Song M., and McClain C. Polyphenols and gastrointestinal diseases. Curr Opin Gastroenterol 22 (2006) 165-170
50. Matsuoka K., Isowa N., Yoshimura T., Liu M., and Wada H. Green tea polyphenol blocks h(2)o(2)-induced interleukin-8 production from human alveolar epithelial cells. Cytokine 18 (2002) 266-273
51. Porath D., Riegger C., Drewe J., and Schwager J. Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell line. J Pharmacol Exp Ther 315 (2005) 1172-1180
52. August D., Landau J., Caputo D., Hong J., and Yang C. Ingestion of green tea rapidly decreases prostaglandin E2 levels in rectal mucosa in humans. Cancer Epidemiol Biomarkers Prev 8 (1999) 709-713
53. Waltner-Law M.E., Wang X.L., Law B.K., Hall R.K., Nawano M., and Granner D.K. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 277 (2002) 34933-34940
54. McKay D.L., and Blumberg J.B. The role of tea in human health: an update. J Am Coll Nutr 21 (2002) 1-13
55. Koyama Y., Abe K., Sano Y., et al. Effects of green tea on gene expression of hepatic gluconeogenic enzymes in vivo. Planta Med 70 (2004) 1100-1102
56. Anderson R., and Polansky M.M. Tea enhances insulin activity. J Agric Food Chem 50 (2002) 7182-7186
57. Kuo P.L., and Lin C.C. Green tea constituent (-)-epigallocatechin-3-gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53-dependent and Fas-mediated pathways. J Biomed Sci 10 (2003) 219-227
58. Levites Y., Weinreb O., Maor G., Youdim M.B., and Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 78 (2001) 1073-1082
59. Melzig M.F., and Janka M. Enhancement of neutral endopeptidase activity in SK-N-SH cells by green tea extract. Phytomedicine 10 (2003) 494-498
60. Ho C.T., Chen Q., Shi H., Zhang K.Q., and Rosen R.T. Antioxidative effect of polyphenol extract prepared from various Chinese teas. Prev Med 21 (1992) 520-525
61. Surh Y.-J. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 428 (1999) 305-327
62. Cao G., Sofic E., and Prior R.L. Antioxidant capacity of tea and common vegetables. J Agric Food Chem 44 (1996) 3426-3431
63. Martínez N., García-Cánovas F., and Rodríguez-López J.N. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans. J Antimicrob Chemother 57 (2006) 1083-1092
64. Dulloo A.G., Duret C., Rohrer D., et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 70 (1999) 1040-1045
65. Westerterp-Plantenga M.S., Lejeune M.P., and Kovacs E.M. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res 13 (2005) 1195-1204
66. Yung-Hsi K., Hiipakka R., and Shutsung L. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 141 (2000) 980-987
67. Srichairatanakool S., Ounjaijean S., Thephinlap C., Khansuwan U., Phisalpong C., and Fucharoen S. Iron-chelating and free-radical scavenging activities of microwave-processed green tea in iron overload. Hemoglobin 30 (2006) 311-327
68. Taylor J.R., and Wilt V.M. Probable antagonism of warfarin by green tea. Ann Pharmacother 33 (1999) 426-428